DNA nitrogenous bases

DNA nitrogenous bases—adenine, guanine, cytosine, and thymine—are the fundamental components of the genetic code, responsible for the storage and transmission of biological information through specific hydrogen-bonded pairing (NHGRI, 2024). In the context of therapeutics, these bases serve as primary targets for a wide range of cytotoxic and anti-infective agents. Alkylating agents like cisplatin and cyclophosphamide form covalent bonds with nitrogenous bases (particularly guanine), leading to DNA cross-linking and the inhibition of replication (StatPearls, 2023). Antimetabolites, such as 5-fluorouracil and gemcitabine, act as structural analogs that are incorporated into DNA or inhibit the synthesis of natural bases, ultimately triggering apoptosis in rapidly proliferating cells (StatPearls, 2024). Intercalating agents like doxorubicin wedge themselves between base pairs, disrupting the helical structure and interfering with topoisomerase activity (PubMed, 2021). While highly effective in treating various cancers and viral infections, the non-specific nature of targeting DNA bases often leads to significant toxicity in healthy tissues, including bone marrow and the gastrointestinal tract. Furthermore, the potential for these agents to induce new mutations poses a risk for secondary malignancies later in life. Targeting these bases remains a cornerstone of modern chemotherapy and antiviral treatment regimens despite the narrow therapeutic index.

Other names

NucleobasesNitrogenous basesDNA basesPurines and PyrimidinesNucleic acid bases

Drugs target DNA nitrogenous bases through several mechanisms: alkylating agents form covalent adducts (typically at the N7 position of guanine) to cause cross-linking; antimetabolites serve as base analogs that disrupt nucleotide synthesis or cause chain termination; and intercalators wedge between base pairs to deform the DNA helix and inhibit topoisomerases (StatPearls, 2023; Nature Reviews Cancer, 2004).